MoneyWorks4Me

Shree Ganesh Remed. reports Profit after tax of Rs 23.37 Mln, in the June 2021 quarter

13 Jul 2021 Evaluate
A decent increase of about 41.56% in the sales to Rs. 126.33 millions was observed for the quarter ended June 2021. The sales figure stood at Rs. 89.24 millions during the year-ago period.Good  Net Profit growth of 41.64% reported above the corresponding previous quarter figure of Rs. 16.50 millions to Rs. 23.37 millioins.Operating profit for the quarter ended June 2021 rose to 41.63 millions as compared to 26.15 millions of corresponding quarter ended June 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202106 202006 % Var 202106 202006 % Var 202103 202003 % Var
Sales 126.33 89.24 41.56 126.33 89.24 41.56 490.82 584.26 -15.99
Other Income 11.08 9.38 18.12 11.08 9.38 18.12 20.95 41.78 -49.86
PBIDT 41.63 26.15 59.20 41.63 26.15 59.20 157.42 151.26 4.07
Interest 0.70 0.23 204.35 0.70 0.23 204.35 0.68 1.41 -51.77
PBDT 40.93 25.92 57.91 40.93 25.92 57.91 156.74 149.85 4.60
Depreciation 8.15 5.52 47.64 8.15 5.52 47.64 27.25 22.41 21.60
PBT 32.78 20.40 60.69 32.78 20.40 60.69 129.49 127.44 1.61
TAX 9.41 3.90 141.28 9.41 3.90 141.28 31.96 31.20 2.44
Deferred Tax -0.03 0.12 -125.00 -0.03 0.12 -125.00 -0.36 -0.56 -35.71
PAT 23.37 16.50 41.64 23.37 16.50 41.64 97.53 96.24 1.34
Equity 100.06 89.71 11.54 100.06 89.71 11.54 100.06 89.71 11.54
PBIDTM(%) 32.95 29.30 12.46 32.95 29.30 12.46 32.07 25.89 23.89
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..